U.S., Nov. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07931014) titled 'CArdiac STereotactic Radiation Treatment for Ablation of ventRicular Tachycardia' on Oct. 20.
Brief Summary: The investigator-initiated, CArdiac Stereotactic radiation Treatment for Ablation of ventRicular tachycardia (CASTAR) study will be conducted in patients with ventricular tachycardia (VT) which is either refractory to antiarrhythmic medication therapy in maximal dose or to catheter ablation or with contraindications to antiarrhythmic medication or catheter ablation.
The study is a non-randomized, multicenter, interventional study of cardiac SBRT, for which a total dose of 25 Gy will be delivered in a single fraction using vo...